Acute Myeloid Leukemia Treated With With NETrin Abs in Combination With [AZACITIDINE + VENETOCLAX]
Status:
Recruiting
Trial end date:
2027-11-30
Target enrollment:
Participant gender:
Summary
The aim of this study is to investigate the safety and the clinical activities of NP137 when
combined with Azacitidine and Venetoclax in patients with refractory acute myeloid leukemia
after 2 cycles of Azacitidine and Venetoclax.